On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Guillermo Garcia‐Manero

ResearcherPublications, citations & collaboration network

Guillermo Garcia‐Manero is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Guillermo Garcia‐Manero have?

ScholarIQindexed works

Guillermo Garcia‐Manero has 3,030 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Guillermo Garcia‐Manero have?

ScholarIQcitation count

Guillermo Garcia‐Manero has 91,104 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Guillermo Garcia‐Manero?

ScholarIQh-index

Guillermo Garcia‐Manero has an h-index of 151 in OpenAlex.

What is the i10-index of Guillermo Garcia‐Manero?

ScholarIQi10-index

Guillermo Garcia‐Manero has an i10-index of 1,041 in OpenAlex.

What is the ORCID of Guillermo Garcia‐Manero?

ScholarIQorcid

The ORCID for Guillermo Garcia‐Manero is on the source record.

What is the OpenAlex record for Guillermo Garcia‐Manero?

ScholarIQopenalex

The OpenAlex for Guillermo Garcia‐Manero is on the source record.

What are the most-cited papers on Guillermo Garcia‐Manero?

ScholarIQmost cited works
Chemoimmunotherapy With Fludarabine, Cyclophosphamide, and Rituximab for Relapsed and Refractory Chronic Lymphocytic Leukemia
William G. Wierda, Susan O’Brien, Sijin Wen, Stefan Faderl, Guillermo Garcia‐Manero, Deborah A. Thomas, Kim‐Anh Do, Jörge E. Cortes, Charles Koller, Miloslav Beran, Alessandra Ferrajoli, Francis J. Giles, Susan Lerner, Maher Albitar, Hagop M. Kantarjian, Michael J. Keating
Journal of Clinical Oncology. 2005524 Citations
DNA Methylation Changes after 5-Aza-2′-Deoxycytidine Therapy in Patients with Leukemia
Allen S. Yang, Ketan D. Doshi, Sang‐Woon Choi, Joel B. Mason, Rajan K. Mannari, Vazganush Gharybian, Rene Luna, Asif Rashid, Lanlan Shen, Marcos R. Estecio, Hagop M. Kantarjian, Guillermo Garcia‐Manero, Jean‐Pierre J. Issa
Cancer Research. 2006268 Citations
Phase I First-in-Human Dose Escalation Study of the oral SF3B1 modulator H3B-8800 in myeloid neoplasms
David P. Steensma, Martin Wermke, Virginia M. Klimek, Peter L. Greenberg, Patricia Font, Rami S. Komrokji, Jay Yang, Andrew M. Brunner, Hetty E. Carraway, Lionel Adès, Aref Al‐Kali, Juan Manuel Alonso‐Domínguez, Ana Alfonso Piérola, Catherine C. Coombs, H. Joachim Deeg, Ian W. Flinn, James M. Foran, Guillermo Garcia‐Manero, Michael B. Maris, Malgorzata McMasters, Jean‐Baptiste Micol, Jaime Pérez de Oteyza, Felicitas Thol, Eunice S. Wang, Justin M. Watts, Justin Taylor, Richard M. Stone, Vikram Gourineni, Alyssa J. Marino, Huilan Yao, Benoit Destenaves, Xiaobin Yuan, Kun Yu, Sara Dar, Lernik Ohanjanian, Keisuke Kuida, Jianjun Xiao, Catherine Scholz, Antonio Gualberto, Uwe Platzbecker
Leukemia. 2021184 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account